Karttunen P, Tukiainen H, Nykänen S, Saano V
Int J Clin Pharmacol Ther Toxicol. 1985 Mar;23(3):161-5.
We have carried out a steady state pharmacokinetic comparison of three different theophylline preparations in nine healthy volunteers using a once a day dosage schedule of 600 mg theophylline given before bedtime for four days. The preparations tested were Retafyllin 200 mg depot tablet (R), Theo-Dur 200 mg depot tablet (T) and Uniphyllin 200 mg tablet (U). All preparations in steady state reached the serum level of 8.9-10.2 microg/ml after a single evening dose of theophylline 600 mg. The pharmacokinetic profile of these slow release theophylline preparations was such that there is no risk of exceeding the therapeutic range even after a rather high evening dose. Individual variation was also observed in the present study but nobody exceeded the therapeutic range. The pharmacokinetic profiles of R and U were quite similar and they seemed to have suitable pharmacokinetic properties for once a day dosage, and they showed a more sustained action than T. Only minimal gastrointestinal side effects were reported during this study.
我们在9名健康志愿者中进行了三种不同茶碱制剂的稳态药代动力学比较,采用睡前每日一次服用600mg茶碱,连续服用四天的给药方案。所测试的制剂为瑞塔菲林200mg长效片(R)、舒弗美200mg长效片(T)和优喘平200mg片(U)。单次晚间服用600mg茶碱后,所有处于稳态的制剂血清水平均达到8.9 - 10.2μg/ml。这些缓释茶碱制剂的药代动力学特征表明,即使晚间剂量较高,也不存在超过治疗范围的风险。本研究中也观察到了个体差异,但无人超过治疗范围。R和U的药代动力学特征相当相似,它们似乎具有适合每日一次给药的药代动力学特性,并且与T相比作用更持久。本研究期间仅报告了轻微的胃肠道副作用。